UN Statistics Division · Health

New Zealand: Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine

60Percentage · 2024-35.5% since 2014

UN SDG Global Database series SH_ACS_PCV3, for SDG indicator 3.b.1. Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (Percentage). Annual figures for New Zealand from 2009 to 2024.

20092024

Every year

YearValue (Percentage)Note
202460
202373
202286
202195
202092
201991
201896
201794
201693
201593
201493
201393
201292
201192
201089
200987

Source

Published by UN Statistics Division, produced by UN Statistics Division. Licence: UN terms of use (reuse with attribution). Retrieved 2026-11-15.

The dataset for every country, with quality and provenance →

Cite or download

UN Statistics Division (2026). Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine. Interva. https://interva.co/dataset/unsdg-sh-acs-pcv3-percent (accessed 2026-11-21). catalog snapshot 2026-11-15.

JSON, New ZealandAPI and MCP

Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine in other countries

Rank New Zealand against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

New Zealand: Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (2009–2024) · Interva